13 February 2026NewsCareersMarisa Woutersen

Norton Rose Fulbright expands pharma and biotech disputes team

The firm recruits two Cooley partners with expertise in Hatch-Waxman, BPCIA, trade secrets, and competitor versus competitor patent litigation.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Careers

Dechert boosts litigation bench with partner duo

25 March 2026 Two senior hires from a rival firm bring litigation expertise across life sciences and tech disputes.

Careers

US firm boosts patent bench with Desmarais hire

18 March 2026 A new partner hire at the firm brings rare depth across both the ITC and district courts in technology and life sciences.

Careers

HSF Kramer hires patent litigator as partner in Germany

17 March 2026 New recruit, who has worked on more than 150 infringement cases, will join the firm’s disputes practice in Düsseldorf and strengthen its UPC offering.

More features

mRNA litigation: Who’s winning, who’s filing, and what’s next

Dechert boosts litigation bench with partner duo

UK court deals blow to Spanish pharma’s SPC bid for contraceptive

EPO reports record patent filings, but pharma and biotech lag

Part II: The race to replace semaglutide heats up

Part I: Ozempic goes generic as Novo’s key patent expires

Masimo convinces judge that Apple took secrets—but it’s not enough

Sandoz strikes fresh biosimilar deal with South Korean biotech

Norton Rose Fulbright expands pharma and biotech disputes team

More on this story

Editor's picks

Editor's picks

More features